TNF and hepatocellular carcinoma: More importantly, unlike TNF-α (26), the aforementioned predictor for RFS which was not influenced by sorafenib treatment, PD-L1 expression was significantly upregulated upon exposure to sorafenib and in sorafenib-resistant HCC (20, 31, 33), and also in relapsed HCC (19).